Title : Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.

Pub. Date : 2006 Mar 16

PMID : 16542442






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy. Docetaxel bromodomain containing 4 Homo sapiens
2 CONCLUSION: Docetaxel may be considered for initial chemotherapy in young patients presenting with a midline carcinoma with bone marrow involvement and cytogenetic and molecular genetic finding of a t(15;19)/BRD4-NUT-rearrangement. Docetaxel bromodomain containing 4 Homo sapiens